Damora Therapeutics, Inc.
DMRAPharmaceutical Preparations · SIC 2834 · CIK 0001800315
Revenue FY2025
—
Net Income
$(210.0M)
EPS (Basic)
—
Net Margin
—
ROE
-87.3%
Total Equity
$240.0M
Shares Out
62M
Damora Therapeutics, Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2019–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 3 funds in our universe
Insider Transactions
Reading stored insider transactions…